SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor - Concepedia

Concepedia

Publication | Open Access

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

DOI Full Paper Access

21.1K

Citations

59

References

2020

Year

Markus Hoffmann, Hannah Kleine‐Weber, Simon Schroeder, Nadine Krüger, Tanja Herrler, Sandra Erichsen, Tobias S. Schiergens, Georg Herrler, Nai-Huei Wu, Andreas Nitsche,

MedicineViral PathogenesisImmunologyIs BlockedVirologyAntiviral Drug DevelopmentAntiviral ResponseViral Structural ProteinSars-cov-2 Cell EntryCell BiologyCovid-19

References

	Year	Citations

Page 1

Page 1